跳至主要内容
临床试验/NCT04070690
NCT04070690Unknown不适用

The Influences of Dialysate Bicarbonate Concentrations on Hemodialysis Patients

Camillians Saint Mary's Hospital Luodong2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
60
试验地点
2
主要终点
Blood pressure during the hemodialysis

研究概览

简要总结

Background:

Patients with decreased kidney function are in the positive acid balance due to insufficient renal acid excretion. To correct the varying degrees of metabolic acidosis in these HD patients, a high concentration of HCO3 in the dialysate is routinely used.

During every 3-to-4 hours of HD treatment, a massive surge of HCO3 would enter the circulation and typically overcorrects predialysis acidosis to alkalosis and alkalemia.

The sharp acid-base shift can cause some adverse consequences.

The investigators believe that the rapid correction (or overcorrection) from the pre-dialysis metabolic acidosis to post-dialysis metabolic alkalosis during the 3-to-4 hours HD treatment would relate to adverse effects on HD patients.

Thus the investigators conduct this study to prove the hypothesis that "prevention of post-dialysis alkalosis by using lower dialysate HCO3 concentration might cause less adverse outcomes in ESRD patients on HD."

Study design:

Prospective cross-over case-control study.

Study population:

A total of 60 patients who receive regular hemodialysis (three times per week) for more than 6 months in the regional teaching hospital.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult uremic patients who received hemodialysis thrice weekly

排除标准

  • Hospitalized patients
  • Patients newly initiated on HD (<6 months)
  • Patients with HD access problems
  • Patients recently discharged from the hospital (within one month).
  • Patients on chemotherapy for cancer.
  • Patients with a kidney transplant.
  • Patients on steroids or other immunosuppressive therapy.
  • Patients with recent surgery (within one month)
  • Patients with an active bacterial infection.
  • Patients with decompensated cirrhosis.

研究组 & 干预措施

Intervention-Control group

Other

In this group, the participants will receive "intervention" for 2 months first, followed by a wash-out period of 1 month and "control" for 2 months.

In the "intervention period," the investigators will provide the participants with lower dialysate HCO3 concentrations. (dialysate HCO3 to 28 mmol/L for half of the HD session and 30 to the second half of their HD session.) Besides, the investigators will give the participants with pre-HD HCO3<22 mEq/L oral Na-bicarbonate 650 mg 1#-2# three times a day as supplements.

In the "control period," the investigators will provide the participants with dialysate HCO3 concentration of 38-40 mEq/L (as we usually provide to patients).

干预措施: Concentration of dialysate bicarbonate (Procedure)

Control-Intervention group

Other

In this group, the participants will receive "control" for 2 months first, followed by a wash-out period of 1 month and "intervention" for 2 months.

In the "control period," the investigators will provide the participants with dialysate HCO3 concentration of 38-40 mEq/L (as we usually provide to patients).

In the "intervention period," the investigators will provide the participants with lower dialysate HCO3 concentrations. (dialysate HCO3 to 28 mmol/L for half of the HD session and 30 to the second half of their HD session.) Besides, the investigators will give the participants with pre-HD HCO3<22 mEq/L oral Na-bicarbonate 650 mg 1#-2# three times a day as supplements.

干预措施: Concentration of dialysate bicarbonate (Procedure)

结局指标

主要结局

Blood pressure during the hemodialysis

时间窗: four months

Blood pressure will be measured every 1 hour during the hemodialysis

O2 saturation during the hemodialysis

时间窗: four months

O2 saturation will be measured every 1 hour during the hemodialysis

Respiratory rate during the hemodialysis

时间窗: four months

Respiratory rate will be measured every 1 hour during the hemodialysis

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chih-Chung Shiao, MD

Director, Dept. of Medical Research and Education, Saint Mary's Hospital Luodong

Camillians Saint Mary's Hospital Luodong

研究点 (2)

Loading locations...

相似试验

The Influences of Dialysate Bicarbonate... | 临床试验